Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances.

ABSTRACT: As the leading malignancy among women, breast cancer is a serious threat to the life and health of women. In this context, it is of particular importance that a proper therapeutic target be identified for breast cancer treatment. We collected the pathological tissues of 80 patients, with the view to discovering appropriate molecular targets for the treatment of breast cancer, this paper analyzes the expressions of ZNF436, β-catenin, EGFR and CMTM5 in breast cancer tissues, as well as their correlations with breast cancer in combination with the clinicopathologic characteristics of studied patients. Immunohistochemistry (IHC) was utilized to detect the expression levels of ZNF436, β-catenin, EGFR and CMTM5 in cancerous and paracancerous tissues of breast cancer patients. The expression leve

SUBMITTER: Chen Z 

PROVIDER: S-EPMC7856825 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature